Influx and Efflux of N,N,N-Trimethyl-N-Prop-2-Ynylammonium by a Rat Brain Synaptosome Preparation

  • L. A. Barker
Part of the Advances in Behavioral Biology book series (ABBI, volume 25)


Several analogs of choline (Ch) have been studied as substrates for the Ch uptake systems present in synaptosomes or brain slices (4–7,9,12,13,15). These analogs are monoethylcholine, diethylcholine, triethylcholine, pyrrolidinecholine, homocholine, sulfocholine, l,l-dimethyl-3-hydroxypiperidine, N-(4-hydroxylbutyl)-N,N, N-trimethylammonium (TMHBA) and N,N-dimethylaminoethanol (DJIAE), and all have a free hydroxyl group. With the exceptions of TMHBA (16) and DMAE (15) they are alternative substrates for the high affinity Ch uptake system as well as precursors to false cholinergic transmitters. These findings and the results of studies on Ch analogs as inhibitors of the high affinity uptake of Ch (22) define some, of the structural requirements for alternative substrates. To be recognized as a substrate, it appears that the Ch analog must be a simple alkyl ammonium or sulfonium that has no more than three methylene groups between the quaternary head and terminal hydroxyl group. The observation that acetylcholine (ACh) is not transported by the high affinity Ch uptake system suggests that a free hydroxyl group also is required for a Ch analog to be a substrate for this transport (17,18). To test this notion, a Ch analog devoid of a hydroxyl group, N,N,N-trimethyl-N-prop-2-ynylammonium (TMPYA), was evaluated as a substrate for the Ch high affinity uptake system. TMPYA was chosen on the basis that the electrostatic potential it generates is quite similar to that of Ch (25). On that basis, TMPYA should be recognized by and interact with binding sites for Ch (see 24 for review). Further, the high affinity transport of Ch, monoethylcholine, pyrrolidinecholine, and homocholine by rat brain synaptosomes is so closely linked to acetylation (3,7,28), it is difficult to study this uptake system separately from the associated metabolism of the substrates. Thus it is desireable to have a non- metabolizable analog of the natural substrate for transport studies. The preliminary results of studies on one such analog, TMPYA, are reported here.


Alternative Substrate High Affinity Site High Affinity Transport High Affinity Uptake Choline Acetyl Transferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barker, L.A. (1976): Life Sci. 18:725–732.CrossRefGoogle Scholar
  2. 2.
    Barker, L.A., Dowdall, M.J. and Whittaker, V.P. (1972): Biochem. J. 130:1063–1080.Google Scholar
  3. 3.
    Barker, L.A. and Mittag, T.W. (1973): FEBS Lett. 35:141–144.CrossRefGoogle Scholar
  4. 4.
    Barker, L.A. and Mittag, T.W. (1975): J. Pharmacol. Exp. Ther. 192:86–94.Google Scholar
  5. 5.
    Chiou, C.Y. (1974): 14:1721–1733.Google Scholar
  6. 6.
    Collier, B., Boksa, P. and Lovat, S. (1979): Prog. Brain Res. 451:107–121.CrossRefGoogle Scholar
  7. 7.
    Collier, B., Lovat, S., Ilson, D., Barker, L.A. and Mittag, T. W. (1977): J. Neurochem. 28:331–340.CrossRefGoogle Scholar
  8. 8.
    Diamond, I. and Kennedy, E.T. (1969): J. Biol. Chem. 244:3258–3263.Google Scholar
  9. 9.
    Frankenberg, L., Heimburger, G., Nilson, G. and Sorbo, B. (1973): Eur. J. Pharmacol. 23:37.CrossRefGoogle Scholar
  10. 10.
    Gibson, G.E., Jope, R. and Blass, J.P. (1975): Biochem. J. 148:17–23.Google Scholar
  11. 11.
    Haga, T. and Nöda, H. (1973): Biochem. Biophys. Acta 291:564–575.CrossRefGoogle Scholar
  12. 12.
    Hemsworth, B.A., Shreeve, S.M. and Veitch, G.B.A. (1979): Brit.J. Pharmacol. 66:.465P.Google Scholar
  13. 13.
    Howard-Butcher, S., Cho, A.K. and Schaeffer, J.C. (1974): Fed. Proc. 13:1660.Google Scholar
  14. 14.
    Jope, R.S. and Jenden, D.J. (1977): Life Sci. 20:1389–1393.CrossRefGoogle Scholar
  15. 15.
    Jope, R.S. and Jenden, D.J. (1979): J. Pharmacol. Exp. Ther. 211:472–479.Google Scholar
  16. 16.
    Jope, R.S., Weiler, M.H. and Jenden, D.J. (1978): Neurochemistry 30:949–954.CrossRefGoogle Scholar
  17. 17.
    Kuhar, M.J. (1978): IN Cholinergic Mechanisms and Psychopharma-cology (ed) D.J. Jenden, Plenum Press, New York, pp. 447–456.CrossRefGoogle Scholar
  18. 18.
    Kuhar, M.J. and Simon, J.R. (1974): J. Neurochem. 22:1135–1137.CrossRefGoogle Scholar
  19. 19.
    Maldonado, M.E., Oh, K.-J. and Frey, P.A. (1972): J. Biol. Chem. 247:2711–2716.Google Scholar
  20. 20.
    Murrin, L.C. and Kuhar, M.J. (1976): Molec. Pharmacol. 12:1082–1090.Google Scholar
  21. 21.
    Roskoski, R. (1978): J. Neurochem. 30:1357–1361.CrossRefGoogle Scholar
  22. 22.
    Simon, J.R., Mittag, T.W. and Kuhar, M.J. (1975): Biochem. Pharmacol. 24:1139–1142.CrossRefGoogle Scholar
  23. 23.
    Weiler, M., Jope, R.S. and Jenden, D.J. (1978): J. Neurochem. 31: 789–796.CrossRefGoogle Scholar
  24. 24.
    Weinstein, H. (1975): Int. J. Quant. Chem. QBS 2:59–69.Google Scholar
  25. 25.
    Weinstein, H., Maayani, S., Srebrenik, S., Cohen, S. And Sokolovsky, M. (1973): Molec. Pharmacol. 9:820–834.Google Scholar
  26. 26.
    Wheeler, D.D. (1978): J. Neurochem. 31:109–120.CrossRefGoogle Scholar
  27. 27.
    Wheeler, D.D. (1979): J. Neurochem. 32:1197–1213.CrossRefGoogle Scholar
  28. 28.
    Yamamura, H.I. and Snyder, S.H. (1973): J. Neurochem. 21: 1255–1374.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • L. A. Barker
    • 1
  1. 1.Department of PharmacologyMt. Sinai School of Medicine City University of New YorkNew YorkUSA

Personalised recommendations